Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Wipro
WIT
$19.3B
| $11.5M | 0.01% |
6,278,534
+1,556,000
| +33% | +$3.05M |
|
1302
ICICI Bank
IBN
$106B
| $11.4M | 0.01% |
939,850
-330,100
| -26% | -$3.87M |
|
|
AKS
1303
DELISTED
AK Steel Holding Corp
AKS
| $11.4M | 0.01% |
5,039,571
+2,975,000
| +144% | +$7.14M |
|
1304
Ardelyx
ARDX
$1.03B
| $11.4M | 0.01% |
2,432,134
+332,064
| +16% | +$1.15M |
|
1305
First Bancorp
FBP
$4.53B
| $11.4M | 0.01% |
1,144,578
-238,835
| -17% | -$2.42M |
|
|
RVNC
1306
DELISTED
Revance Therapeutics, Inc.
RVNC
| $11.4M | 0.01% |
876,373
-454,600
| -34% | -$5.56M |
|
1307
Starwood Property Trust
STWD
$6.09B
| $11.4M | 0.01% |
+469,084
| New | +$11.1M |
|
|
HTBK
1308
DELISTED
Heritage Commerce
HTBK
| $11.4M | 0.01% |
966,171
-78,629
| -8% | -$934K |
|
|
SHI
1309
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $11.3M | 0.01% |
388,408
+198,208
| +104% | +$6.5M |
|
1310
Conagra Brands
CAG
$7.47B
| $11.3M | 0.01% |
+368,800
| New | +$10.6M |
|
1311
MSC Industrial Direct
MSM
$6.85B
| $11.3M | 0.01% |
156,000
-15,700
| -9% | -$1.1M |
|
1312
CytomX Therapeutics
CTMX
$719M
| $11.3M | 0.01% |
1,532,300
+125,300
| +9% | +$1.24M |
|
1313
Rush Enterprises Class B
RUSHB
$9.35B
| $11.3M | 0.01% |
636,525
-15,300
| -2% | -$266K |
|
1314
NVE Corp
NVEC
$576M
| $11.3M | 0.01% |
170,200
+39,323
| +30% | +$2.68M |
|
1315
DHI Group
DHX
$169M
| $11.3M | 0.01% |
2,932,700
+130,300
| +5% | +$484K |
|
|
UFS
1316
DELISTED
DOMTAR CORPORATION (New)
UFS
| $11.3M | 0.01% |
314,142
-60,800
| -16% | -$2.26M |
|
1317
St. Joe Company
JOE
$3.87B
| $11.2M | 0.01% |
655,071
+156,271
| +31% | +$2.77M |
|
1318
German American Bancorp
GABC
$1.93B
| $11.2M | 0.01% |
349,400
+24,350
| +7% | +$750K |
|
1319
First American
FAF
$7.51B
| $11.1M | 0.01% |
188,500
+125,600
| +200% | +$7.19M |
|
1320
Timberland Bancorp
TSBK
$358M
| $11.1M | 0.01% |
404,369
-1,370
| -0.3% | -$36K |
|
1321
Manchester United
MANU
$4.07B
| $11.1M | 0.01% |
674,900
+80,863
| +14% | +$1.42M |
|
1322
Ceragon Networks
CRNT
$199M
| $11.1M | 0.01% |
4,121,500
-253,400
| -6% | -$666K |
|
|
HNGR
1323
DELISTED
Hanger Inc.
HNGR
| $11.1M | 0.01% |
543,262
+106,862
| +24% | +$2.01M |
|
1324
Diamondrock Hospitality Co
DRH
$2.53B
| $11.1M | 0.01% |
1,079,684
+756,326
| +234% | +$7.46M |
|
|
SRC
1325
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $11.1M | 0.01% |
231,240
-861,594
| -79% | -$39.5M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.